As of April 19, 2025, Entera Bio (ENTX) has a market cap of $81.303 million USD. According to our data, Entera Bio is ranked No.7732 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $81.30 M |
4.12%
|
Dec 31, 2024 | $78.08 M |
253.33%
|
Dec 29, 2023 | $22.10 M |
-17.81%
|
Dec 30, 2022 | $26.89 M |
-74.07%
|
Dec 31, 2021 | $0.10 B |
160.65%
|
Dec 31, 2020 | $39.78 M |
-49.53%
|
Dec 31, 2019 | $78.82 M |
-29.84%
|
Dec 31, 2018 | $0.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Novo Nordisk
NVO
|
$285.37 B |
89.978 B
|
![]() Denmark
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.66 B |
0.000 M
|
![]() Israel
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
Market Cap | = | ENTX Stock Price | * | ENTX Shares Outstanding |
= | $1.79 | * | 45.42 M | |
= | $81.30 M |